Lamarche N, Matton G, Massie B, Fontecave M, Atta M, Dumas F, Gaudreau P, Langelier Y
Institut du cancer de Montréal, Hôpital Notre-Dame, Canada.
Biochem J. 1996 Nov 15;320 ( Pt 1)(Pt 1):129-35. doi: 10.1042/bj3200129.
The R2 subunit of ribonucleotide reductase from herpes simplex virus type 2 was overproduced with prokaryotic and eukaryotic expression systems. The recombinant R2 purified by a two-step procedure exhibited a 3-fold higher activity when produced in eukaryotic cells. Precise quantification of the R2 concentration at each step of the purification indicated that the activity was not altered during the purification procedure. Moreover, we have observed that the level of R2 expression, in eukaryotic cells as well as in prokaryotic cells, did not influence R2 activity. Extensive characterization of the recombinant R2 purified from eukaryotic and prokaryotic expression systems has shown that both types of pure R2 preparations were similar in their 76 kDa dimer contents (more than 95%) and in their ability to bind the R1 subunit. However, we have found that the higher activity of R2 produced in eukaryotic cells is more probably related to a higher capability of binding the iron cofactor as well as a 3-fold greater ability to generate the tyrosyl free radical.
利用原核和真核表达系统过量表达了单纯疱疹病毒2型核糖核苷酸还原酶的R2亚基。通过两步法纯化的重组R2在真核细胞中产生时活性高3倍。在纯化的每个步骤对R2浓度进行精确定量表明,活性在纯化过程中未发生改变。此外,我们观察到,真核细胞和原核细胞中R2的表达水平均不影响R2活性。对从真核和原核表达系统纯化的重组R2进行的广泛表征表明,两种类型的纯R2制剂在其76 kDa二聚体含量(超过95%)以及结合R1亚基的能力方面相似。然而,我们发现,真核细胞中产生的R2较高的活性更可能与结合铁辅因子的能力较高以及产生酪氨酰自由基的能力高3倍有关。